These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 17906980)

  • 1. Papillary microcarcinoma of the thyroid gland: is the immunohistochemical expression of cyclin D1 or galectin-3 in primary tumour an indicator of metastatic disease?
    Londero SC; Godballe C; Krogdahl A; Bastholt L; Specht L; Sørensen CH; Pedersen HB; Pedersen U; Christiansen P
    Acta Oncol; 2008; 47(3):451-7. PubMed ID: 17906980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of cyclin D1 gene expression as a prognostic factor in benign and malignant thyroid lesions.
    Brzeziańska E; Cyniak-Magierska A; Sporny S; Pastuszak-Lewandoska D; Lewiński A
    Neuro Endocrinol Lett; 2007 Aug; 28(4):341-50. PubMed ID: 17693985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclin D1 overexpression in thyroid papillary microcarcinoma: its association with tumour size and aberrant beta-catenin expression.
    Lantsov D; Meirmanov S; Nakashima M; Kondo H; Saenko V; Naruke Y; Namba H; Ito M; Abrosimov A; Lushnikov E; Sekine I; Yamashita Sh
    Histopathology; 2005 Sep; 47(3):248-56. PubMed ID: 16115225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclin D1 expression in primary thyroid carcinomas.
    Sporny S; Slowinska-Klencka D; Ratynska M
    Neuro Endocrinol Lett; 2005 Dec; 26(6):815-8. PubMed ID: 16380680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galectin-3 expression in papillary microcarcinoma of the thyroid.
    Cvejic D; Savin S; Petrovic I; Paunovic I; Tatic S; Krgovic K; Havelka M
    Histopathology; 2005 Aug; 47(2):209-14. PubMed ID: 16045783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survivin and cyclin D1 are jointly expressed in thyroid papillary carcinoma and microcarcinoma.
    Antonaci A; Consorti F; Mardente S; Natalizi S; Giovannone G; Della Rocca C
    Oncol Rep; 2008 Jul; 20(1):63-7. PubMed ID: 18575719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of nuclear, cytoplasmic expression of galectin-3 with beta-catenin/Wnt-pathway activation in thyroid carcinoma.
    Weinberger PM; Adam BL; Gourin CG; Moretz WH; Bollag RJ; Wang BY; Liu Z; Lee JR; Terris DJ
    Arch Otolaryngol Head Neck Surg; 2007 May; 133(5):503-10. PubMed ID: 17515507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyroid peroxidase and galectin-3 immunostaining in differentiated thyroid carcinoma with clinicopathologic correlation.
    Savin S; Cvejic D; Isic T; Paunovic I; Tatic S; Havelka M
    Hum Pathol; 2008 Nov; 39(11):1656-63. PubMed ID: 18657294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclin D1 protein expression in human thyroid gland and thyroid cancer.
    Temmim L; Ebraheem AK; Baker H; Sinowatz F
    Anat Histol Embryol; 2006 Apr; 35(2):125-9. PubMed ID: 16542178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Galectin-3 and proliferating cell nuclear antigen (PCNA) expression in papillary thyroid carcinoma.
    Cvejic D; Savin S; Petrovic I; Selemetjev S; Paunovic I; Tatic S; Havelka M
    Exp Oncol; 2005 Sep; 27(3):210-4. PubMed ID: 16244583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclin D1 protein expression predicts metastatic behavior in thyroid papillary microcarcinomas but is not associated with gene amplification.
    Khoo ML; Ezzat S; Freeman JL; Asa SL
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1810-3. PubMed ID: 11932322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclin D1 in well differentiated thyroid tumour of uncertain malignant potential.
    Lamba Saini M; Weynand B; Rahier J; Mourad M; Hamoir M; Marbaix E
    Diagn Pathol; 2015 Apr; 10():32. PubMed ID: 25907675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell cycle regulators show diagnostic and prognostic utility for differentiated thyroid cancer.
    Melck A; Masoudi H; Griffith OL; Rajput A; Wilkins G; Bugis S; Jones SJ; Wiseman SM
    Ann Surg Oncol; 2007 Dec; 14(12):3403-11. PubMed ID: 17882495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Galectin-3 expression in papillary thyroid carcinoma: relation to histomorphologic growth pattern, lymph node metastasis, extrathyroid invasion, and tumor size.
    Cvejic DS; Savin SB; Petrovic IM; Paunovic IR; Tatic SB; Havelka MJ
    Head Neck; 2005 Dec; 27(12):1049-55. PubMed ID: 16155918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased type 1 iodothyronine deiodinase expression might be an early and discrete event in thyroid cell dedifferentation towards papillary carcinoma.
    de Souza Meyer EL; Dora JM; Wagner MS; Maia AL
    Clin Endocrinol (Oxf); 2005 Jun; 62(6):672-8. PubMed ID: 15943828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermal growth factor receptor expression in serous ovarian carcinoma: an immunohistochemical study with galectin-3 and cyclin D1 and outcome.
    Brustmann H
    Int J Gynecol Pathol; 2008 Jul; 27(3):380-9. PubMed ID: 18580315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of a combination of galectin-3 and thyroid peroxidase for the diagnosis and prognosis of thyroid cancer.
    Weber KB; Shroyer KR; Heinz DE; Nawaz S; Said MS; Haugen BR
    Am J Clin Pathol; 2004 Oct; 122(4):524-31. PubMed ID: 15487449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of Galectin-3 and Galectin-7 in thyroid malignancy as potential diagnostic indicators.
    Than TH; Swethadri GK; Wong J; Ahmad T; Jamil D; Maganlal RK; Hamdi MM; Abdullah MS
    Singapore Med J; 2008 Apr; 49(4):333-8. PubMed ID: 18418527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unusual findings in papillary thyroid microcarcinoma suggesting partial regression: a study of two cases.
    Simpson KW; Albores-Saavedra J
    Ann Diagn Pathol; 2007 Apr; 11(2):97-102. PubMed ID: 17349567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and histopathological behavior of papillary microcarcinomas: study of 429 cases.
    Pakdaman MN; Rochon L; Gologan O; Tamilia M; Garfield N; Hier MP; Black MJ; Payne RJ
    Otolaryngol Head Neck Surg; 2008 Nov; 139(5):718-22. PubMed ID: 18984270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.